NASDAQ · Medical - Healthcare Information Services

GE HealthCare Technologies Inc. (GEHC) Stock

$69.57 -1.11% NASDAQ: GEHC Healthcare

Valuation

MetricValue
Price$69.57
Market Cap$31.42B
P/E Ratio18.82
P/B Ratio2.70
P/S Ratio1.46
EPS (TTM)$4.55
52-Week High$89.77
52-Week Low$58.75
Dividend Yield0.24%

Financials & Margins

MetricValue
ROE15.16%
ROA4.27%
ROCE8.88%
Gross Margin42.55%
Operating Margin12.46%
Net Margin7.86%
Debt/Equity0.92
Current Ratio1.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.6B$18.3B$19.6B$19.7B$20.6B
Operating Profit$2.8B$2.5B$2.4B$2.6B$2.8B
Net Profit$2.2B$1.9B$1.6B$2.0B$2.1B
EPS$4.90$4.22$3.02$4.34$4.55
Op Margin15.9%13.8%12.4%13.3%13.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$26.3B$27.5B$32.5B$33.1B$36.9B
Total Liabilities$9.4B$17.9B$25.1B$24.4B$26.3B
Cash$556.0M$1.4B$2.5B$2.9B$4.5B
Borrowings$437.0M$8.6B$9.9B$9.4B$10.0B

Latest News

Can GE HealthCare (GEHC) Turn Theranostic Partnerships Into a Durable Advanced Diagnostics Edge? Simply Wall St. · Jul 15, 2026 Daily – Vickers Top Insider Picks for 07/15/2026 Argus Research · Jul 15, 2026 Do Options Traders Know Something About GE HealthCare Stock We Don't? Zacks · Jul 14, 2026 Daily – Vickers Top Insider Picks for 07/14/2026 Argus Research · Jul 14, 2026 BTIG Research Adjusts GE Healthcare Technologies Price Target to $75 From $80, Maintains Buy Rating MT Newswires · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.6B$2.1B$2.1B$2.0B$2.0B
Investing Cash Flow$-2.0B$-708.0M$-945.0M$-1.3B$-1.5B
Financing Cash Flow$-251.0M$-9.0B$-1.6B$-128.0M$-323.0M
Net Cash Flow$-451.0M$890.0M$1.1B$387.0M$1.6B
Free Cash Flow$1.4B$1.8B$1.7B$1.6B$1.5B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.65
EV / EBITDA10.81
FCF Yield3.03%
Quick Ratio0.72
Interest Coverage5.90
Return 1Y-4.21%
Return 3Y5.57%
Return 5Y—

Ownership

Insiders Held0.35%
Institutions Held93.86%
Institutions Float Held94.19%
Institutional HolderSharesReport Date
Blackrock Inc.35,984,3272026-03-31
Dodge & Cox Inc.31,312,0642026-03-31
Vanguard Capital Management LLC28,864,1882026-03-31
Capital Research Global Investors21,108,7532026-03-31
State Street Corporation20,538,4762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $343.46 +0.43% 38.93 $5.01T 0.32%
MSFTMicrosoft Corporation $529.05 -1.93% 28.68 $3.93T 0.76%
GOOGLAlphabet Inc. $340.59 -2.47% 16.94 $4.15T 0.26%
AMZNAmazon.com, Inc. $250.00 -1.87% 19.82 $2.70T 0.00%
METAMeta Platforms, Inc. $709.33 -3.72% 27.93 $1.81T 0.28%

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is led by CEO Peter J. Arduini, employs 53,000 people, headquartered in Chicago, US, publicly traded since 2022.

GE HealthCare Technologies Inc. (GEHC) stock trades at $69.57 with a market capitalization of $31.42B. The stock is valued at a price-to-earnings (P/E) ratio of 18.82, price-to-book of 2.70, price-to-sales of 1.46. Over the past 52 weeks the stock has ranged between $58.75 and $89.77, and currently trades 22.5% below its 52-week high. It pays a dividend yielding 0.24%.

On profitability, GE HealthCare Technologies Inc. generates a return on equity (ROE) of 15.16%, above the typical market range of roughly 12-15%, return on capital employed of 8.88%, an operating margin of 12.46%, a net profit margin of 7.86%.

In its most recent fiscal year, GE HealthCare Technologies Inc. reported annual revenue of $20.6B, net profit of $2.1B. Over the last 5 fiscal years, revenue grew at an average annual rate of 3.7%, and net profit declined at an average annual rate of 31.5%.

The balance sheet shows a debt-to-equity ratio of 0.92, a current ratio of 1.18, total assets of $36.9B, $4.5B in cash and equivalents.

GEHC has an average daily trading volume of 4,215,858 shares, a beta of 0.82.

Related Healthcare Stocks

LLY Eli Lilly and Company $1257.03 +0.43% JNJ Johnson & Johnson $255.56 +0.90% ABBV AbbVie Inc. $285.42 +0.71% UNH UnitedHealth Group Incorporated Common Stock (DE) $401.43 -1.29% MRK Merck & Company, Inc. Common Stock (new) $145.97 +0.53% NVS Novartis AG $150.62 +0.16% AZN AstraZeneca PLC $165.41 -0.76% TMO Thermo Fisher Scientific Inc $690.00 -0.93% AMGN Amgen Inc. $432.49 -0.35% GILD Gilead Sciences, Inc. $156.19 -0.75% ABT Abbott Laboratories $104.88 +0.19% NVO Novo Nordisk A/S $38.83 -0.99%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.